CD19 and acute lymphoblastic leukemia: For example, one study is using autologous anti-CD19 CAR cells for children with relapsed ALL that incorporate an EGFRt tracking/suicide construct and a methotrexate-resistance gene (clinicaltrials.gov identifier NCT01683279).